Par Sterile Products, LLC

“Providing patients and customers with uncompromising quality and value.”

Quality You Can Depend On

The legacy of Par Sterile Products reaches back to the birth of the American pharmaceutical industry at the turn of the 20th century. Our Rochester, Mich., location represents one of the landmark manufacturing facilities in the history of our industry. Our iconic brands such as Aplisol^® and Adrenalin^® have been relied upon by physicians and patients for decades. While proud of our heritage, we are even prouder of the great things we are accomplishing today. In an injectables world frequently plagued by compliance issues and product shortages, Par Sterile Products stands as a highly regarded partner with exemplary trade service levels and an impeccable record of regulatory compliance. In return for the trust that is placed in us, we are committed to providing products of uncompromising quality. In fulfilling this mission, we deliver value to our customers and the physicians and patients who rely on us.

Partners for Health Care Excellence

Par Pharmaceutical, headquartered in Chestnut Ridge, N.Y., develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par’s differentiated portfolio includes alternative dosage products as well as many products that are difficult to manufacture. Additionally, the Par portfolio includes both branded and generic sterile injectable products, distributed by Par Sterile Products. Par Pharmaceutical is advancing a research and development (R&D) pipeline of nearly 250 potential new products. The combination of the Qualitest and Par businesses (known collectively as Par Pharmaceutical) was completed in September 2015 and expands Endo’s generics business to a top 4 industry leader. Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL), a global specialty pharmaceutical company focused on improving patients’ lives while creating shareholder value. Learn more at www.endo.com, www.parpharm.com or www.parsterileproducts.com.

Promising Product Pipeline

Par Sterile Products currently markets a portfolio of 20 specialty injectable products, including Vasostrict^®, Brevital^®, Dantrium^®, Pitocin^®, dexmedetomidine and ethacrynate sodium. Since 2013, Par Sterile Products has launched eight new products. We possess a robust new product pipeline in the injectable space, having developed a pipeline of 19 products, more than half of which have been submitted for FDA approval. We expect a half-dozen ANDA filings annually, fueled by our commitment to investment in research and development.

At Par Sterile Products, we are large enough to maintain a significant trade presence, yet agile enough to provide maximum attention to our customers, and we remain poised to continue our impressive track record of success. For more information, please visit www.parsterileproducts.com.

PAR—People Achieving Results!

 

This corporate profile was reviewed and approved by Par Sterile Products, LLC.

Close